Autopsy report · NCT03982199

A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

“The study was terminated early by the sponsor due to strategic reprioritization reasons.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 10 months before it stopped.
• 5,815 participants enrolled.
• Results were posted on the registry 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Janssen Vaccines & Prevention B.V.

Sponsor type

Industry

Conditions

Respiratory Syncytial Viruses; Respiratory Tract Diseases

Interventions

RSV Vaccine; Placebo

Participants

5,815

Sites

40

Countries

United States

Trials that died the same way

• A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
  “The study was terminated early as per Sponsor's decision” (89% match in meaning)
• Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
  “This study was terminated by the Sponsor.” (88% match in meaning)
• Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
  “The study was terminated by the sponsor” (87% match in meaning)
• A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
  “The study was terminated due to the sponsor's research and development strategy adjustment.” (86% match in meaning)
• Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)
  “The Sponsor chose to terminate this study for commercial reasons.” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.